Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2003
02/13/2003US20030032041 Electrochemiluminescence helicase assay
02/13/2003US20030032040 Process of quality examining for microarray of biological material
02/13/2003US20030032037 Circular site-directed mutagenesis
02/13/2003US20030032032 Diagnosing viral brain disorders; obtain sample nucleic acids, incubate with marker probe, denature, hybridize, detect signal from probe, presence of signal indicates viral infection
02/13/2003US20030032030 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging
02/13/2003US20030032029 Three dimensional apparatus and method for integrating sample preparation and multiplex assays
02/13/2003US20030032028 In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads
02/13/2003US20030032027 Amplified cancer gene WIP1
02/13/2003US20030032026 Detection and measurement of methylated cytosine in nucleic acid sample; obtain genomic nucleotide sequences, incubate with reaction mixture and label, amplifiy nucleotide sequences, detect and quantify fluorescence
02/13/2003US20030032025 Brassica polymorphisms
02/13/2003US20030032024 Rolling circle replication reporter systems
02/13/2003US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
02/13/2003US20030032022 Variants of IL-1 beta gene and CD46 gene for diagnosing unexplained recurrent pregnancy loss
02/13/2003US20030032020 Generation of nucleotide sequence library; obtain nucleotide sequences, incubate with enzymes, separate into single nucleotide sequences, hybridize sequences, incubate with nuclease and recover nucleotide sequences
02/13/2003US20030032018 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like.
02/13/2003US20030032016 Detecting in nucleic acid molecule; obtain oligonucleotide probes, incubate with sample, expose to polymerase, amplify nucleotide sequence, detect signal from probe, recover signaling nucleotide sequences
02/13/2003US20030032007 Method of detecting microorganisms in a sample
02/13/2003US20030032005 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
02/13/2003US20030032004 Primers and probes derived from the 5' untranslated region of the HCV genome which facilitate detection and/or quantification of all presently known genotypes of HCV.
02/13/2003US20030031999 Determining the translational efficiency of an individual codon in a cell; obtain cell, transform with expression vector, express vector, monitor gene expression and translation
02/13/2003US20030031670 Diagnosis and treatment of malignant neoplasms
02/13/2003US20030031657 Stem cells and their use in transplantation
02/13/2003US20030031625 Detecting the presence of small intestinal bacterial overgrowth in a human subject having at least one symptom associated with a suspected diagnosis of the condition caused by small intestinal bacterial overgrowth
02/13/2003US20030029714 Manipulation of solid, semi-solid or liquid materials
02/13/2003US20030028981 Precision fluorescently dyed particles and methods of making and using same
02/13/2003DE19938138C2 Verfahren und Vorrichtung zur Identifikation einer Biopolymersequenz auf Festkörperoberflächen Method and apparatus for identifying a biopolymer on solid surfaces
02/13/2003DE19937234C2 Borna Disease Virus (BDV)- spezifische Nukleinsäuresequenzen - ihre Anwendung in Diagnostik und Therapie Borna disease virus (BDV) - specific nucleic acid sequences - their use in diagnosis and therapy
02/13/2003CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
02/13/2003CA2456229A1 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
02/13/2003CA2456199A1 Gene associated with bone disorders
02/13/2003CA2456196A1 Compositions and methods for modulation of immune responses
02/13/2003CA2456184A1 Expression profile of prostate cancer
02/13/2003CA2456040A1 Method to detect splice variants of the calcineurin gene
02/13/2003CA2455877A1 Apparatus and method for determining the onset and presence of sepsis conditions
02/13/2003CA2455803A1 Nucleic acid amplification method
02/13/2003CA2455700A1 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit
02/13/2003CA2455686A1 Methods for generating antibiotic resistant microbes and novel antibiotics
02/13/2003CA2455398A1 Use of peptide fragments of the calcium channel .alpha.-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
02/13/2003CA2455325A1 Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids
02/13/2003CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity
02/13/2003CA2455147A1 Pregnancy-related enzyme activity
02/13/2003CA2454937A1 Modulators of notch signalling for use in immunotherapy
02/13/2003CA2454850A1 Nucleic acids and encoded polypeptides associated with bipolar disorder
02/13/2003CA2454700A1 A method to analyze nucleic acid(s) defining gene(s) exhibiting altered expression by schizophrenia
02/13/2003CA2454454A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
02/13/2003CA2454238A1 Method of detecting protease activity in a cell
02/13/2003CA2454159A1 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene
02/13/2003CA2453840A1 Isp-1 and ctb-1 genes and uses thereof
02/13/2003CA2453522A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines
02/12/2003EP1283272A2 Methods and means for assessing HIV envelope inhibitor therapy
02/12/2003EP1283271A1 Method of screening compounds using nematode worms
02/12/2003EP1283261A1 Method of screening drug acting on cell wall
02/12/2003EP1283258A1 Ornithine decarboxylase similar protein and nucleic acid molecules encoding it
02/12/2003EP1283255A1 Myocardial cell proliferation-associated genes
02/12/2003EP1283212A1 Methods for identifying compounds that bind to a target
02/12/2003EP1282827A2 Method for selecting enzyme inhibitors
02/12/2003EP1282825A1 Immunoassay for cereal reserve protein
02/12/2003EP1282824A2 Doped nanoparticles as biolabels
02/12/2003EP1282823A2 Proteolytic enzymes in diagnosis of kidney disorders
02/12/2003EP1282822A2 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen
02/12/2003EP1282819A1 Method for immobilizing recognition components
02/12/2003EP1282816A2 Improved assay techniques using nematode worms
02/12/2003EP1282730A2 Compositions and methods for nucleic acid or polypeptide analyses
02/12/2003EP1282729A2 Microsatellite-aflp
02/12/2003EP1282728A2 Methods for clinical diagnosis
02/12/2003EP1282726A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
02/12/2003EP1282725A2 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFORE, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH AGENTS.
02/12/2003EP1282724A2 Stain solution which is devoid of phenol
02/12/2003EP1282723A1 Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents
02/12/2003EP1282714A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
02/12/2003EP1282706A2 Natrium-calcium exchanger protein
02/12/2003EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor
02/12/2003EP1282701A2 Novel neuronally expressed protein and use thereof
02/12/2003EP1282700A1 Neuronal serine-threonine protein kinase
02/12/2003EP1282696A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same
02/12/2003EP1282692A2 Sentinel virus ii
02/12/2003EP1282689A1 Specific inhibitors of ribosome recycling factor (rrf)
02/12/2003EP1282688A1 Ammonia-oxidizing bacteria
02/12/2003EP1282684A2 Chondroitin synthase gene and methods of making and using same
02/12/2003EP1282643A2 Anti-inflammatory compounds and uses thereof
02/12/2003EP1282639A2 Polyamide nucleic acid derivatives, agents and methods for producing the same
02/12/2003EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
02/12/2003EP1282634A1 Atm mutations in breast cancer
02/12/2003EP1282449A2 Treatment of human papillomavirus (hpv)-infected cells
02/12/2003EP1282417A1 Creatinine biosensor
02/12/2003EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis
02/12/2003EP1206572B1 Method for increasing the hybridization rate of nucleic acids
02/12/2003EP1150942A4 Improved compounds for protein binding
02/12/2003EP1115400A4 Benzothiazole dioxetanes
02/12/2003EP1082460A4 A novel method of diagnosing, monitoring, and staging prostate cancer
02/12/2003EP1080065A4 A method of permanent fluorescent assay
02/12/2003EP0938588B1 Signal amplification method
02/12/2003EP0815261B1 Dna diagnostics based on mass spectrometry
02/12/2003EP0717749B1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
02/12/2003EP0694068B1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs
02/12/2003CN2535796Y Red blood-cell cultivation rotating-bottle machine
02/12/2003CN1397015A Analysis of catalysed reactions by calorimetry
02/12/2003CN1396957A Method and kits for identifying elite event GAT-ZM1 in biological samples
02/12/2003CN1396954A Support for fixing nucleotide and process for producing the same
02/12/2003CN1396272A Process for testing gene chip used to detect bacteremia